Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

NCT01717170 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT01717170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01717170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
Lead sponsor
University of Nebraska
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2013
Completion date
December 31, 2017
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intermediate uveitis, pan-uveitis, posterior uveitis